TGFβ superfamily ligands, on the other hand, signal through heteromeric serine/threonine kinase receptors, resulting in growth inhibition and apoptosis in normal tissue, or immunosuppression and tumor progression in later oncogenic stages and extracellular matrix deposition [164]. The gene discussed is TGFB1; the disease is neoplasm.